Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01613885 · ClinicalTrials.gov registry record
Understanding and Diagnosing Allergic Disease in Twins
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 340
- Enrollment target
NCT01613885: Completed study, sponsored by Stanford University.
NCT01613885 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 340 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01613885 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 340 participants
- Enrollment target
Study Summary
The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.
Primary Outcome
Differences in genetic and phenotypic characteristics between twin siblings
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2010-08 |
| Est. Completion | 2019-10 |
What the finished NCT01613885 record still lists
NCT01613885 is an observational study that tracks outcomes without assigning an intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01613885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01613885 about?
NCT01613885 is a clinical study titled "Understanding and Diagnosing Allergic Disease in Twins". The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.
What is the current status of trial NCT01613885?
This trial is currently completed. The enrollment target is 340 participants. The study started on 2010-08. Estimated completion is 2019-10.
What interventions are being tested in trial NCT01613885?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT01613885?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia